AHR NYSE Earnings call

American Healthcare REIT, Inc. (AHR) · Q2 2026 results and valuation

Share price: $59.23 · 2026-11-11

Results Q2 2026 vs Q1 2026 · previous quarter · published 7 Aug 2026 and 8 May 2026

Net income up 29.1% on the previous quarter. Management sounded about as positive as a typical company call, in its script and in answers to analysts.

Only a basic analysis is available for this company at the moment.

1 · Numbers

+29.1%

Net income vs Q1 2026

Outlook given

Net income 30.6M vs 23.7M

Revenue +3.6%

Against the same quarter last year (Q2 2025) it is +208.9%, so it is not just seasonal.

2 · How management spoke

Typical

More upbeat than 58% of company calls

Answers to analysts: typical, in line with the script.

Similar to last call.

3 · What stood out

Trilogy's same-store quality mix reached 75.5% of resident days, up roughly 60 basis points year over year, aligning with Medicare Advantage payors that value outcomes.

Valuation

Is American Healthcare REIT, Inc. undervalued?

Reverse DCF on net income from the last full fiscal year (no meaningful free cash flow: a bank, insurer or a year of negative cash flow) (2025-12-31), grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.

At 10.0% growth a year (3-year revenue growth), the model's fair value is $8.01 a share — the stock trades 640% above it. Today's price assumes 38.7% growth a year.

Current price

$59.23

close of 2026-11-11

Market implies growth of iThe yearly free-cash-flow growth, for the next 10 years, that today’s share price already assumes. If you believe the company grows faster than this, the stock is cheap under this model; slower, and it is expensive.

+38.7% for 10 yrs

Fair value / share

$8.01

Buy below

$6.01

Price vs fair value

Overvalued >200%

Price vs buy-below price

Overvalued >200%

Read between the lines

  1. Guidance

    Deal flow is very heavy compared to last year, attracting many groups and serving as the big driver.

    Source quote
    “This shift directly reflects Trilogy's continuing focus on alignment with payor sources, especially Medicare Advantage plans, that value quality outcomes... ...improvement in quality mix, which now stands at 75.5% of resident days on a same-store basis, up roughly 60 basis points from a year ago, and up 200 basis points on a total portfolio basis. Trilogy's clinical reputation is what earns its strong census, and we continue to invest in maintaining and...”
  2. Key theme

    AHR expects most or all of the volume to close before year-end but included none of it in guidance, leaving room for results to beat the outlook.

    Source quote
    “We've seen a lot of groups that are coming out basically attracted We are seeing a lot of deal flow compared to even last year, where we started to see a pretty strong uptick -- and this year has just been very heavy. So I'd say that's pretty much the big driver.”
  3. Guidance

    Quality mix reached 75.5% of resident days, continuing Trilogy trends the company expects to see.

    Source quote
    “We expect to close most, if not all, before the end of the year, but none of this volume is reflected in our guidance.”

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q2 2026. Ring: Q1 2026.

Prepared remarks Typical (was typical)
Answers to analysts Typical (was upbeat)

Script and answers carried a similar tone, so the script's message held up under questioning.

Sentences that drove the tone
“Our capital markets discipline has given rise to strong offensive capability, positioning us to pursue our most attractive acquisition and development opportunities from a position of financial strength.”
“This company is strong, the strategy is delivering industry-leading results and the senior leadership team is exceptional.”
“As our standing with operators has continued to strengthen materially and as our balance sheet has become an even stronger foundation for seizing opportunities, more of the right opportunities are...”

Full figures

USD · SEC EDGAR XBRL (10-Q, period end 2026-06-30)

Metric Q2 2026period end 2026-06-30 Q1 2026period end 2026-03-31 Change Q2 2025 YoY
Revenue 674.2M 650.8M +3.6% 542.5M +24.3%
Gross profit 149.4M 138.6M +7.8% 116.2M +28.6%
Operating income 137.2M 125.5M +9.4% 103.2M +32.9%
Net income 30.6M 23.7M +29.1% 9.9M +208.9%
EPS 0.16 0.13 +23.1% 0.06 +166.7%
P/E today 74.2 76.7 79.9 −3.2 12-mo loss —

Topics

Most discussed now

  • New Many of these submarkets represent 5- to 8-year concept of delivery, if you can actually assemble the land and get...
  • Utilizing this strategy, American Healthcare REIT has been able to close $1.4 billion of acquisitions this year, while also creating future…
  • With that, the second quarter put numbers behind the growth and the opportunity American Healthcare REIT is...
  • Beyond what excites me now the most is how HR is positioned to capitalize on one of the most significant...
  • American Healthcare REIT also sold 3 noncore properties for approximately $22.3 million, continuing its ongoing process of…

Faded since Q1 2026

  • Dropped It is an incredibly efficient vehicle for raising capital, and when you can do it on a forward basis, you...
  • Fading Meanwhile, new supply growth across senior housing remains near historic lows.
  • Fading There is nothing bad that happens to it to the extent that number continues to go lower; it really just...
  • Fading Regional presence matters because they can get a regional director to oversee multiple different facilities, and there are synergies from...

Latest announcements

Official filings, newest first.